Free Trial

Owens & Minor (OMI) Competitors

$17.43
+0.18 (+1.04%)
(As of 05/31/2024 ET)

OMI vs. PDCO, MCK, COR, CAH, HSIC, OPCH, DOCS, CYTK, APLS, and MDGL

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Option Care Health (OPCH), Doximity (DOCS), Cytokinetics (CYTK), Apellis Pharmaceuticals (APLS), and Madrigal Pharmaceuticals (MDGL). These companies are all part of the "medical" sector.

Owens & Minor vs.

Patterson Companies (NASDAQ:PDCO) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability.

Patterson Companies has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500.

In the previous week, Patterson Companies had 17 more articles in the media than Owens & Minor. MarketBeat recorded 19 mentions for Patterson Companies and 2 mentions for Owens & Minor. Patterson Companies' average media sentiment score of 0.79 beat Owens & Minor's score of 0.33 indicating that Owens & Minor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
3 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Owens & Minor
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Patterson Companies currently has a consensus target price of $31.67, indicating a potential upside of 28.78%. Owens & Minor has a consensus target price of $23.29, indicating a potential upside of 33.60%. Given Patterson Companies' higher possible upside, analysts clearly believe Owens & Minor is more favorable than Patterson Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Patterson Companies received 111 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.39% of users gave Patterson Companies an outperform vote while only 48.54% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
361
52.39%
Underperform Votes
328
47.61%
Owens & MinorOutperform Votes
250
48.54%
Underperform Votes
265
51.46%

Patterson Companies has a net margin of 2.95% compared to Patterson Companies' net margin of -0.37%. Owens & Minor's return on equity of 20.98% beat Patterson Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies2.95% 20.98% 7.70%
Owens & Minor -0.37%12.97%2.26%

Patterson Companies has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.47B0.34$207.56M$2.0312.11
Owens & Minor$10.33B0.13-$41.30M-$0.51-34.18

85.4% of Patterson Companies shares are held by institutional investors. Comparatively, 98.0% of Owens & Minor shares are held by institutional investors. 1.5% of Patterson Companies shares are held by company insiders. Comparatively, 3.6% of Owens & Minor shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Patterson Companies beats Owens & Minor on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.33B$7.55B$5.13B$17.79B
Dividend YieldN/A2.31%2.75%3.55%
P/E Ratio-34.1818.33167.1725.81
Price / Sales0.131.142,418.7811.40
Price / Cash3.3610.6235.3018.95
Price / Book1.492.215.535.90
Net Income-$41.30M$249.27M$106.01M$976.46M
7 Day Performance-0.57%-0.16%1.14%0.62%
1 Month Performance-27.31%-7.07%1.43%4.79%
1 Year Performance-15.22%-4.49%4.07%24.00%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.2842 of 5 stars
$24.21
+0.8%
$31.67
+30.8%
-6.4%$2.17B$6.57B11.937,600Analyst Downgrade
Analyst Revision
MCK
McKesson
4.7058 of 5 stars
$563.68
+0.9%
$571.47
+1.4%
+46.3%$73.27B$308.95B25.1951,000Insider Selling
Analyst Revision
COR
Cencora
4.205 of 5 stars
$220.65
+0.7%
$233.90
+6.0%
+31.3%$44.01B$262.17B24.1446,000Insider Buying
CAH
Cardinal Health
3.975 of 5 stars
$97.59
+1.5%
$107.57
+10.2%
+19.0%$23.77B$205.01B43.3748,000Analyst Downgrade
Short Interest ↓
HSIC
Henry Schein
3.8443 of 5 stars
$70.05
-0.1%
$81.73
+16.7%
-5.6%$8.97B$12.34B23.6725,000Short Interest ↑
Analyst Revision
OPCH
Option Care Health
4.7643 of 5 stars
$30.16
+2.1%
$40.00
+32.6%
+7.5%$5.24B$4.43B19.847,802Short Interest ↑
DOCS
Doximity
2.5626 of 5 stars
$28.09
-1.5%
$28.73
+2.3%
-12.1%$5.24B$475.42M39.01977News Coverage
CYTK
Cytokinetics
4.106 of 5 stars
$48.69
+1.7%
$74.88
+53.8%
+27.8%$5.11B$7.53M-9.02423Analyst Forecast
APLS
Apellis Pharmaceuticals
4.4693 of 5 stars
$40.81
-0.7%
$76.27
+86.9%
-55.0%$4.95B$396.59M-11.79702Analyst Forecast
Analyst Revision
MDGL
Madrigal Pharmaceuticals
4.6855 of 5 stars
$225.19
+1.2%
$345.09
+53.2%
-12.2%$4.80BN/A-9.75376Positive News

Related Companies and Tools

This page (NYSE:OMI) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners